1. |
Donnelly J, Hackler RH, Bunts RC. Present urologic status of the World War Ⅱ paraplegic: 25-year followup. Camparison with status of the 20-year Korean war paraplegic and 5-year Vietnam paraplegic. J Urol, 1972, 108(4): 558-562.
|
2. |
Borges PM, Hackler RH. The urologic status of the Vietnam war paraplegic: a 15-year prospective followup. J Urol, 1982, 127(4): 710-711.
|
3. |
Noe BB, Stapelfeldt CM, Parner ET, et al. Survival after traumatic spinal cord injury in Denmark: a hospital-based study among patients injured in 1990-2012. Spinal Cord, 2017, 55(4): 373-377.
|
4. |
Welk B, Liu K, Winick-Ng J, et al. Urinary tract infections, urologic surgery, and renal dysfunction in a contemporary cohort of traumatic spinal cord injured patients. Neurourol Urodyn, 2017, 36(3): 640-647.
|
5. |
Andretta E, Pagliacci MC, Zuliani C, et al. A survey of clinical practice concerning long-term follow-up of neurogenic lower urinary tract dysfunction due to spinal cord injury in Italy. J Spinal Cord Med, 2021, 13: 1-9.
|
6. |
Savic G, DeVivo MJ, Frankel HL, et al. Long-term survival after traumatic spinal cord injury: a 70-year British study. Spinal Cord, 2017, 55(7): 651-658.
|
7. |
Wyndaele JJ. The management of neurogenic lower urinary tract dysfunction after spinal cord injury. Nat Rev Urol, 2016, 13(12): 705-714.
|
8. |
Przydacz M, Chlosta P, Corcos J. Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury. Int Urol Nephrol, 2018, 50(6): 1005-1016.
|
9. |
Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol, 2015, 14(7): 720-732.
|
10. |
Wyndaele JJ. Investigating afferent nerve activity from the lower urinary tract: highlighting some basic research techniques and clinical evaluation methods. Neurourol Urodyn, 2010, 29(1): 56-62.
|
11. |
Panicker JN. Neurogenic bladder: epidemiology, diagnosis, and management. Semin Neurol, 2020, 40(5): 569-579.
|
12. |
Rosier PFWM, Schaefer W, Lose G, et al. International continence society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn, 2017, 36(5): 1243-1260.
|
13. |
Winters JC, Dmochowski RR, Goldman HB, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol, 2012, 188(Suppl 6): 2464-2472.
|
14. |
Abrams P, Damaser MS, Niblett P, et al. Air filled, including “air-charged”, catheters in urodynamic studies: does the evidence justify their use?. Neurourol Urodyn, 2017, 36(5): 1234-1242.
|
15. |
Marks BK, Goldman HB. Videourodynamics: indications and technique. Urol Clin North Am, 2014, 41(3): 383-391.
|
16. |
Kocher NJ, Damaser MS, Gill BC. Advances in ambulatory urodynamics. Curr Urol Rep, 2020, 21(10): 41.
|
17. |
Drossaerts J, Rademakers KLJ, Rahnama’i SM, et al. The value of ambulatory urodynamics in the evaluation of treatment effect of sacral neuromodulation. Urol Int, 2019, 102(3): 299-305.
|
18. |
Wyndaele JJ, THi HV, Pham BC, et al. The use of one-channel water cystometry in patients with a spinal cord lesion: practicalities, clinical value and limitations for the diagnosis of neurogenic bladder dysfunction. Spinal Cord, 2009, 47(7): 526-530.
|
19. |
Latthe PM, Foon R, Toozs-Hobson P. Prophylactic antibiotics in urodynamics: a systematic review of effectiveness and safety. Neurourol Urodyn, 2008, 27(3): 167-173.
|
20. |
Samson G, Cardenas DD. Neurogenic bladder in spinal cord injury. Phys Med Rehabil Clin N Am, 2007, 18(2): 255-274.
|
21. |
Romo PGB, Smith CP, Cox A, et al. Non-surgical urologic management of neurogenic bladder after spinal cord injury. World J Urol, 2018, 36(10): 1555-1568.
|
22. |
Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol, 2000, 163(3): 768-772.
|
23. |
Milligan J, Goetz LL, Kennelly MJ. A primary care provider’s guide to management of neurogenic lower urinary tract dysfunction and urinary tract infection after spinal cord injury. Top Spinal Cord Inj Rehabil, 2020, 26(2): 108-115.
|
24. |
Bennett CJ, Young MN, Adkins RH, et al. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol, 1995, 153(5): 1458-1460.
|
25. |
Lapides J, Diokno AC, Silber SJ, et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol, 2017, 197(2S): S122-S124.
|
26. |
De Ridder DJ, Everaert K, Fernández LG, et al. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial. Eur Urol, 2005, 48(6): 991-995.
|
27. |
Ahluwalia RS, Johal N, Kouriefs C, et al. The surgical risk of suprapubic catheter insertion and long-term sequelae. Ann R Coll Surg Engl, 2006, 88(2): 210-213.
|
28. |
Mitsui T, Minami K, Furuno T, et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol, 2000, 38(4): 434-438.
|
29. |
Esclarín De Ruz A, García Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol, 2000, 164(4): 1285-1289.
|
30. |
Schurch B, Stöhrer M, Kramer G, et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol, 2000, 164(3 Pt 1): 692-697.
|
31. |
Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol, 2003, 44(2): 165-174.
|
32. |
杨卫新, 苏敏, 张大伟, 等. 超声引导肉毒毒素注射尿道外括约肌治疗下尿路功能障碍. 中华物理医学与康复杂志, 2013, 35(4): 286-289.
|
33. |
Hansen RB, Biering-Sørensen F, Kristensen JK. Bladder emptying over a period of 10-45 years after a traumatic spinal cord injury. Spinal Cord, 2004, 42(11): 631-637.
|
34. |
Chen SF, Kuo HC. Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: a urologist’s perspective. Low Urin Tract Symptoms, 2022, 14(3): 132-139.
|
35. |
Kennelly M, Dmochowski R, Schulte-Baukloh H, et al. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: final results of a long-term extension study. Neurourol Urodyn, 2017, 36(2): 368-375.
|
36. |
Wyndaele JJ, Maes D. Clean intermittent self-catheterization: a 12-year followup. J Urol, 1990, 143(5): 906-908.
|
37. |
Šámal V, Paldus V, Fáčková D, et al. The prevalence of antibiotic-resistant and multidrug-resistant bacteria in urine cultures from inpatients with spinal cord injuries and disorders: an 8-year, single-center study. BMC Infect Dis, 2022, 22(1): 239.
|
38. |
Vaidyanathan S, Soni BM, Dundas S, et al. Urethral cytology in spinal cord injury patients performing intermittent catheterisation. Paraplegia, 1994, 32(7): 493-500.
|
39. |
Wyndaele JJ, Vodušek DB. Approach to the male patient with lower urinary tract dysfunction. Handb Clin Neurol, 2015, 130: 143-64.
|
40. |
Bellucci CH, Wöllner J, Gregorini F, et al. Acute spinal cord injury-do ambulatory patients need urodynamic investigations?. J Urol, 2013, 189(4): 1369-1373.
|
41. |
Bartel P, Krebs J, Wöllner J, et al. Bladder stones in patients with spinal cord injury: a long-term study. Spinal Cord, 2014, 52(4): 295-297.
|
42. |
Antunes-Lopes T, Pinto R, Barros SC, et al. Urinary neurotrophic factors in healthy individuals and patients with overactive bladder. J Urol, 2013, 189(1): 359-365.
|
43. |
Ni J, Suzuki T, Karnup SV, et al. Nerve growth factor-mediated Na+ channel plasticity of bladder afferent neurons in mice with spinal cord injury. Life Sci, 2022, 298: 120524.
|
44. |
Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women. BJU Int, 2008, 102(10): 1440-1444.
|
45. |
Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol, 2009, 56(4): 700-706.
|
46. |
Liu HT, Liu AB, Chancellor MB, et al. Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident. BJU Int, 2009, 104(8): 1158-1162.
|
47. |
Frias B, Santos J, Morgado M, et al. The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO). J Neurosci, 2015, 35(5): 2146-2160.
|
48. |
Saito T, Gotoh D, Wada N, et al. Time-dependent progression of neurogenic lower urinary tract dysfunction after spinal cord injury in the mouse model. Am J Physiol Renal Physiol, 2021, 321(1): F26-F32.
|